Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 21801777)

1.

Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.

Domm W, Brooks L, Chung HL, Feng C, Bowers WJ, Watson G, McGrath JL, Dewhurst S.

Vaccine. 2011 Sep 16;29(40):7080-9. doi: 10.1016/j.vaccine.2011.07.008. Epub 2011 Jul 27.

2.

Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Excler JL, Ake J, Robb ML, Kim JH, Plotkin SA.

Clin Vaccine Immunol. 2014 Aug;21(8):1023-36. doi: 10.1128/CVI.00230-14. Epub 2014 Jun 11. Review.

3.

Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.

Mestecky J, Wei Q, Alexander R, Raska M, Novak J, Moldoveanu Z.

Am J Reprod Immunol. 2014 Jun;71(6):600-7. doi: 10.1111/aji.12203. Epub 2014 Feb 5. Review.

PMID:
24494997
4.

Adeno-associated virus delivery of broadly neutralizing antibodies.

Schnepp BC, Johnson PR.

Curr Opin HIV AIDS. 2014 May;9(3):250-6. doi: 10.1097/COH.0000000000000056. Review.

5.

Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.

Lewis GK, DeVico AL, Gallo RC.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15614-21. doi: 10.1073/pnas.1413550111. Epub 2014 Oct 27. Review.

6.

Replicating and non-replicating viral vectors for vaccine development.

Robert-Guroff M.

Curr Opin Biotechnol. 2007 Dec;18(6):546-56. Epub 2007 Dec 11. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk